I Peace partners with the California Institute for Regenerative Medicine [CIRM]

I Peace logo

PALO ALTO, Calif., Nov. 1, 2022 /PRNewswire/ — I Peace, Inc. (https://www.ipeace.com) announced that the company has agreed to join the California Institute for Regenerative Medicine’s (CIRM) Industry Resource Partner Program to pave way for the provision of Good Manufacturing Practice (GMP) iPSCs for various research programs funded by CIRM. I Peace has been providing GMP Induced Pluripotent […]

Parkinson’s & Stem Cell Therapy Research

Parkinson's and stem cell therapy research

Stem cells are the body’s building blocks, capable of multiplying itself and creating other differentiated cells. Every day, scientists are learning more and more about their potential, and the use of these cells as an internal repair system. From laboratory test tubes to human trials, stem cells are giving new hope to a myriad of […]

When Should Stem Cell Transplants Be Considered for MPN Treatment?

Stem Cell Transplants Considered for MPN Treatment

Dr. Jeanne Palmer, an MPN specialist, discusses when a stem cell transplant is an appropriate treatment option and provides an overview of how risk is assessed in MPN patients. Dr. Jeanne Palmer is a hematologist specializing in myeloproliferative neoplasms (MPNs) and bone marrow transplant at the Mayo Clinic in Arizona. Dr. Palmer also serves as […]

Perinatal Stem Cell Society Calls Emergency Session to Garner Industry Support for FDA

Perinatal Stem Cell Society logo

FORT LAUDERDALE, Fla., Oct. 26, 2022 /PRNewswire/ — The Perinatal Stem Cell Society has organized a workshop Nov. 3 in Fort Lauderdale, Fla. and streamed to unite the biologics industry and work with the FDA towards a patient-centered goal. “I called this one-day workshop so the industry can partner with the Food and Drug Administration to find solutions that will enable […]

Developing Regenerative Medicines featuring Dr. Stefan Irion

Dr Stefan Irion - developing regenerative medicines

In episode 228 of the Stem Cell Podcast, Dr. Dayklin James and Dr. Arun Sharma chat with Dr. Stefan Irion, Senior Vice President of Research at BlueRock Therapeutics, a leading engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases. He talks about the company’s Parkinson’s disease trial and the challenges […]

The Journey of a Cancer-Fighting Stem Cell Therapy

Dr Ravi Majeti - journey of a cancer-fighting stem cell therapy

Frontiers in Medicine 2022 gathered Stanford Medicine’s scientific and philanthropic communities in the historic Frost Amphitheater to explore a future of medicine that is both innovative and human-centered. A future that harnesses AI and big data to transform how we deliver care. A future where knowledge of human biology at a cellular, molecular, and genomic […]

Emulating the heart – Developing blood stem cells to treat cancer

developing blood stem cells to treat cancer

Making stem cells from a patient’s adult cells – rather than human embryos – is one of the holy grails in modern medicine treatments. New research brings us two steps closer. *** All content on NationalStemCellTherapy.com is for informational purposes only. All medical questions and concerns should always be consulted with your licensed healthcare provider.

Global Mesenchymal Stem Cells (MSC) Market to Reach $6.5 Billion by 2027

Report Linker logo

New York, Oct. 19, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Mesenchymal Stem Cells (MSC) Industry” – https://www.reportlinker.com/p05961465/?utm_source=GNWOnline interactive peer-to-peer collaborative bespoke updatesAccess to our digital archives and MarketGlass Research PlatformComplimentary updates for one year Global Mesenchymal Stem Cells (MSC) Market to Reach $6.5 Billion by 2027 Amid the COVID-19 crisis, […]